We focus on gastroenterology
Tillotts Pharma AG (“Tillotts”), part of the Japanese Zeria Group, is a fast-growing specialty pharmaceutical company with over 300 employees worldwide.
Today, our products are available in over 65 countries through our affiliates in Europe, our parent company Zeria and a strategic partnership network throughout the world. Tillotts is headquartered in Rheinfelden, Switzerland close to Basel. For more information about Tillotts, please take a look here:
Since its foundation, Tillotts has been committed to improving care for people with gastrointestinal (GI) diseases. We collaborate with healthcare professionals and GI-experts to develop and market medicines for the treatment of diseases of the digestive system.
Our specific focus on the digestive system means we have in-depth knowledge of the challenges that gastroenterologists and hepatologists face on a daily basis. It also helps us look for innovative ways to improve care and quality of life for the 5–6 million people who live with inflammatory bowel diseases worldwide.
At Tillotts, we are dedicated to advancing our employees’ skills and supporting them with their professional development. We encourage individuals’ involvement in all aspects of the business in which they are interested, to gain a deeper insight into the full picture. In order to do this, we offer a variety of leadership training and support with further education.